1. Home
  2. SNSE vs DUO Comparison

SNSE vs DUO Comparison

Compare SNSE & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • DUO
  • Stock Information
  • Founded
  • SNSE 2005
  • DUO 2011
  • Country
  • SNSE United States
  • DUO China
  • Employees
  • SNSE N/A
  • DUO N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • SNSE Health Care
  • DUO Finance
  • Exchange
  • SNSE Nasdaq
  • DUO Nasdaq
  • Market Cap
  • SNSE 10.8M
  • DUO 11.4M
  • IPO Year
  • SNSE 2021
  • DUO 2019
  • Fundamental
  • Price
  • SNSE $7.76
  • DUO $1.69
  • Analyst Decision
  • SNSE Strong Buy
  • DUO
  • Analyst Count
  • SNSE 4
  • DUO 0
  • Target Price
  • SNSE $72.50
  • DUO N/A
  • AVG Volume (30 Days)
  • SNSE 25.9K
  • DUO 270.5K
  • Earning Date
  • SNSE 08-05-2025
  • DUO 08-29-2025
  • Dividend Yield
  • SNSE N/A
  • DUO N/A
  • EPS Growth
  • SNSE N/A
  • DUO N/A
  • EPS
  • SNSE N/A
  • DUO 7.57
  • Revenue
  • SNSE N/A
  • DUO $46,458,330.00
  • Revenue This Year
  • SNSE N/A
  • DUO N/A
  • Revenue Next Year
  • SNSE N/A
  • DUO N/A
  • P/E Ratio
  • SNSE N/A
  • DUO $0.23
  • Revenue Growth
  • SNSE N/A
  • DUO 19.00
  • 52 Week Low
  • SNSE $5.00
  • DUO $1.69
  • 52 Week High
  • SNSE $17.40
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 52.43
  • DUO 26.77
  • Support Level
  • SNSE $6.33
  • DUO $1.69
  • Resistance Level
  • SNSE $10.99
  • DUO $2.22
  • Average True Range (ATR)
  • SNSE 1.00
  • DUO 0.12
  • MACD
  • SNSE 0.12
  • DUO -0.02
  • Stochastic Oscillator
  • SNSE 41.04
  • DUO 3.01

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: